Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Capital Expenditures (2023 - 2025)

Historic Capital Expenditures for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $74000.0.

  • Metagenomi's Capital Expenditures fell 9383.33% to $74000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $823000.0, marking a year-over-year decrease of 8177.99%. This contributed to the annual value of $3.1 million for FY2024, which is 6826.98% down from last year.
  • As of Q3 2025, Metagenomi's Capital Expenditures stood at $74000.0, which was down 9383.33% from $127000.0 recorded in Q2 2025.
  • Metagenomi's 5-year Capital Expenditures high stood at $3.2 million for Q2 2023, and its period low was $74000.0 during Q3 2025.
  • For the 3-year period, Metagenomi's Capital Expenditures averaged around $1.2 million, with its median value being $915000.0 (2024).
  • As far as peak fluctuations go, Metagenomi's Capital Expenditures crashed by 4687.92% in 2024, and later tumbled by 9383.33% in 2025.
  • Quarter analysis of 3 years shows Metagenomi's Capital Expenditures stood at $1.7 million in 2023, then crashed by 80.77% to $334000.0 in 2024, then plummeted by 77.84% to $74000.0 in 2025.
  • Its Capital Expenditures stands at $74000.0 for Q3 2025, versus $127000.0 for Q2 2025 and $288000.0 for Q1 2025.